BIOMAT Database Logo BIOMAT Database Logo

Multiple sclerosis in Isfahan, Iran: an update. 2014

Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Department of Neurology, Isfahan University of Medical Sciences, Iran Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan University of Medical Sciences, Iran.

UI MeSH Term Description Entries
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D017668 Age of Onset The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age-at-Onset,Age at Onset,Onset Age

Related Publications

Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Multiple sclerosis in Isfahan, Iran.
January 2007, International review of neurobiology,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Prevalence of multiple sclerosis in Isfahan, Iran.
January 2006, Neuroepidemiology,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Multiple sclerosis among Afghan immigrants in Isfahan, Iran.
April 2017, Multiple sclerosis and related disorders,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
June 2007, Multiple sclerosis (Houndmills, Basingstoke, England),
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran.
January 2019, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
April 2007, Archives of Iranian medicine,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
April 2007, European journal of neurology,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
August 2011, Multiple sclerosis (Houndmills, Basingstoke, England),
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran.
January 2017, Caspian journal of internal medicine,
Masoud Etemadifar, and Seyed-Hossein Abtahi, and Mojtaba Akbari, and Richard T Murray, and Sreeram V Ramagopalan, and Mahboobeh Fereidan-Esfahani
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
March 2010, Multiple sclerosis (Houndmills, Basingstoke, England),
Copied contents to your clipboard!